Chiglitazar Added to SGLT-2 Inhibitors for Type 2 Diabetes

NCT07580638 · clinicaltrials.gov ↗

NOT_YET_RECRUITING

Status

3550

Enrollment

INDUSTRY

Sponsor class

Conditions

T2DM (Type 2 Diabetes Mellitus)

Interventions

DRUG: SGLT-2 inhibitor and Chiglitazar
DRUG: SGLT-2 inhibitor and Other Oral Antidiabetic Drugs (OADs)

Sponsor

Chipscreen Biosciences, Ltd.